---
title: "Health Care Up on Safe-Haven Demand — Health Care Roundup"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302027612.md"
description: "Health care stocks rose due to safe-haven demand and rotation into defensive sectors. UnitedHealth Group shares gained over 3%, driven by reduced fears about its business model. Drug makers also saw gains as tech sector volatility increased. AstraZeneca rose 2.9% after announcing a partnership with AI startup Insitro for disease research, valued up to $1.5 billion."
datetime: "2026-10-15T21:49:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302027612.md)
  - [en](https://longbridge.com/en/news/302027612.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302027612.md)
generator: "portal-rs"
---

# Health Care Up on Safe-Haven Demand — Health Care Roundup

Health-care companies rose as a rotation into defensive health insurers and Big Pharma companies continued.

Shares of UnitedHealth Group rose by more than 3%, and are now up by more than 8% during the last month as fears about the company's business model subsided. 

Shares of drug makers also gained as artificial-intelligence jitters struck the tech sector. 

Shares of AstraZeneca rose 2.9% to $166.68 after the British drug maker said it was teaming up with startup Insitro to tap AI for disease research in a deal valued at as much as $1.5 billion. 

Write to Rob Curran at rob.curran@dowjones.com 

(END) Dow Jones Newswires

October 15, 2026 17:40 ET (21:40 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [UNH.US](https://longbridge.com/en/quote/UNH.US.md)
- [UN.US](https://longbridge.com/en/quote/UN.US.md)
- [UNHG.US](https://longbridge.com/en/quote/UNHG.US.md)
- [UNHU.US](https://longbridge.com/en/quote/UNHU.US.md)
- [UNHW.US](https://longbridge.com/en/quote/UNHW.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)

## Related News & Research

- [AstraZeneca’s Imfinzi combination cuts death risk 42% in bladder cancer trial](https://longbridge.com/en/news/302966653.md)
- [AstraZeneca (AZN) Hits EFS, OS in VOLGA; Cuts Death Risk 42% in MIBC](https://longbridge.com/en/news/302966723.md)
- [AstraZeneca's Ultomiris gains US accelerated approval to reduce proteinuria in adults with IgAN](https://longbridge.com/en/news/302617076.md)
- [AstraZeneca's Ultomiris Gets FDA Accelerated Approval As First C5 Inhibitor For IgAN](https://longbridge.com/en/news/302673006.md)
- [AstraZeneca’s Sone-Ve improves overall survival in Phase III gastric cancer trial](https://longbridge.com/en/news/302246560.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**